Yang Jing-Hua, Luo Xiaoxing, Nie Yongzhan, Su Yingjun, Zhao Qingchuan, Kabir Koroush, Zhang Dexin, Rabinovici Reuven
Department of Surgery, Yale University School of Medicine, New Haven, CT 06520, USA.
Immunology. 2003 May;109(1):15-23. doi: 10.1046/j.1365-2567.2003.01598.x.
Adenosine-to-inosine (A-to-I) RNA editing is a post-transcriptional modification of pre-mRNA catalysed by an RNA-specific adenosine deaminase (ADAR). A-to-I RNA editing has been previously reported in the pre-mRNAs of brain glutamate and serotonin receptors and in lung tissue during inflammation. Here we report that systemic inflammation markedly induces inosine-containing mRNA to approximately 5% of adenosine in total mRNA. Induction was the result of up-regulation of A-to-I RNA editing as both dsRNA editing activity and ADAR1 expression were increased in the spleen, thymus and peripheral lymphocytes from endotoxin-treated mice. Up-regulation of ADAR1 was confirmed in vitro in T lymphocytes and macrophages stimulated with a variety of inflammatory mediators including tumour necrosis factor-alpha and interferon-gamma. A late induction of RNA editing was detected in concanavalin A-activated splenocytes stimulated with interleukin-2 in vitro. Taken together, these data suggest that a large number of inosine-containing mRNAs are produced during acute inflammation via up-regulation of ADAR1-mediated RNA editing. These events may affect the inflammatory and immune response through modulation of protein production.
腺苷到次黄苷(A-to-I)RNA编辑是一种由RNA特异性腺苷脱氨酶(ADAR)催化的前体mRNA的转录后修饰。此前已报道在脑谷氨酸和5-羟色胺受体的前体mRNA以及炎症期间的肺组织中存在A-to-I RNA编辑。在此我们报道,全身炎症显著诱导含次黄苷的mRNA在总mRNA中占腺苷的比例达到约5%。这种诱导是A-to-I RNA编辑上调的结果,因为在内毒素处理小鼠的脾脏、胸腺和外周淋巴细胞中,双链RNA编辑活性和ADAR1表达均增加。在用包括肿瘤坏死因子-α和干扰素-γ在内的多种炎症介质刺激的T淋巴细胞和巨噬细胞中,体外证实了ADAR1的上调。在体外,用白细胞介素-2刺激伴刀豆球蛋白A激活的脾细胞时,检测到RNA编辑的晚期诱导。综上所述,这些数据表明在急性炎症期间,通过ADAR1介导的RNA编辑上调产生了大量含次黄苷的mRNA。这些事件可能通过调节蛋白质产生来影响炎症和免疫反应。